Clinical Research Informer

Controlling Diabetes: Advances & Adherence

Pharmaceutical Commerce

JUNE 10, 2022

Proper control of type 1 and 2 diabetes can greatly reduce the personal impact and economic burden of this pervasive public health condition. To that end, stakeholders are exploring many parallel routes to help individuals and society maintain the upper hand, as the toll of diabetes continues to skyrocket.

How Heart Attack Survivors Can Improve Lifestyle Factors with a Text Messaging Program

XTalks

MAY 17, 2022

The TEXT messages to improve MEDication adherence and Secondary prevention after acute coronary syndrome study (TEXTMEDS) evaluated the effect of the personalized text messaging support program on medication adherence and lifestyle changes among individuals discharged from hospital after a heart attack.

FDA Approval

FDA Approval Research Life Science Medicine

PI Focus: Velocity PI Leads Breakthrough Efforts to Combat Obesity, Diabetes

Velocity Clinical Research

JUNE 22, 2023

The Velocity Clinical Research team in Los Angeles, CA, is tackling two of the biggest health threats to Americans today: obesity and diabetes. Consider these sobering statistics from the Centers for Disease Control and Protection (CDC): The U.S. obesity prevalence was 42% in 2017 – March 2020. obesity prevalence increased from 30.5%

Clinical Trials

Clinical Trials Clinical Trials Clinical Research FDA Approval

Up to 73% of Atopic Dermatitis Patients Taking Lilly’s Lebrikizumab Had Improved or Cleared Skin on Face or Hands in New Analysis

The Pharma Data

MAY 1, 2023

These results from the ADvocate and ADhere studies were presented at the 5 th annual Revolutionizing Atopic Dermatitis (RAD) Congress. Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients 12 years of age and older with moderate-to-severe AD. .

Dermatology

Dermatology Medicine Clinical Trials Clinical Trials

Bad behaviour: why understanding human behaviour can improve outcomes

pharmaphorum

AUGUST 10, 2020

Human behaviour underpins our actions towards medication adherence, physical activity, tobacco and drug use. Advances in digital tools and medical devices have also enabled better outcomes through better decisions. More systematic approaches to understanding behaviour and the interventions that support change appear in the literature.

Genetics

Genetics Drug Delivery Research Pharma Companies

Striving to Deliver Better Outcomes: Janssen to Showcase Commitment to.

The Pharma Data

AUGUST 31, 2021

Compelled to advance innovation for patients and the urology community, oral presentations highlight real-world effectiveness of and patient adherence to ERLEADA ® (apalutamide), plus PSA response from Phase 3 TITAN and SPARTAN studies in patients with advanced prostate cancer. Podium Presentations. Abstract # PD05-08.

Drug Delivery Systems

Drug Delivery Systems Drug Delivery Trials Drugs

Patient Centricity in Insulin Delivery: Improving the Injection Experience with Droplet Micron

XTalks

FEBRUARY 24, 2021

Carl Ward, GM at HTL-STREFA, explained the gravity of a type 1 diabetes diagnosed. He recounted a personal experience of how a friend was caught up in emotion over his 14-year-old daughter’s type 1 diabetes diagnosis as he turned to Ward for information and assistance. Unmet Need in Type 1 Diabetes Care.

Insulin

Insulin Production Drug Delivery Marketing

Why aren’t digital pills taking off?

Pharmaceutical Technology

AUGUST 8, 2022

Controlling the parameters of our health with an app has become comfortable, and many people welcome this type of progress,” says Marina Morla Gonzalez, an assistant lecturer in the public law department at Universidad de León in Spain. So, it's not essentially a ‘he said, she said’ about adherence, but this is more like what happened….'I'm

FDA Approval

FDA Approval Medicine Trials Drugs

Fixed-dose combination of albuterol and budesonide (PT027) demonstrated significant benefits.

The Pharma Data

SEPTEMBER 9, 2021

The trial included 3,132 patients with moderate to severe asthma taking maintenance ICS with or without additional controller medicines. 4 These patients are at risk of severe exacerbations regardless of their disease severity, adherence to treatment or level of control. AstraZeneca and Avillion collaboration.

Trials

Trials Medicine Allergies Dermatology

The Future Of Healthcare: Wearable Injectors Unveiled

Roots Analysis

SEPTEMBER 22, 2023

These devices have potential to offer enhanced convenience, improved medication adherence and empowering patients to take control of their treatment regimens. These devices are equipped with advanced features like programmable dosing, connectivity to mobile apps, and safety mechanisms to ensure accurate and controlled drug delivery.

Drug Delivery

Drug Delivery Marketing Insulin Manufacturing

Huma’s Kaushik Gune on SaMD and the Company’s Partnership with Bayer

XTalks

JULY 10, 2023

SaMD represents a new era where algorithms, artificial intelligence, and advanced analytics converge to provide accurate diagnoses, personalized treatments, and continuous monitoring. We did not get a Class II certification for diabetes only, or orthopedics or cardiology; we got a disease-agnostic certification.

Life Science

Life Science Cardiology Regulation Pharma Companies

The Future of Drug Delivery: Exploring Large Volume Wearable Injectors

Roots Analysis

SEPTEMBER 18, 2023

With the increasing global population, the incidence rates of several chronic disease indications, such as diabetes, heart disorders, neurological disorders and oncological disorders, are on the rise. Therefore, medical technology is rapidly evolving, enabling more advanced and patient-friendly methods of drug delivery.

Drug Delivery

Drug Delivery Drugs Compliance Marketing

Overcoming challenges in obesity-related clinical trials

Drug Discovery World

APRIL 10, 2024

Semaglutide, a long-acting injectable GLP-1 RA, has shown excellent weight loss efficacy in obese non-diabetic patients, and is being further developed as an oral formulation. Adherence reminders and check-ins can also be helpful in keeping the clinical trial fresh in the minds of participants.

Clinical Trials

Clinical Trials Clinical Trials Trials Hormones

Novartis’ KESTREL Study Reaffirms Positive Results of Beovu in DME

The Pharma Data

DECEMBER 15, 2020

On Tuesday, Novartis announced the first interpretable results from its Phase III KESTREL study of humanized single-chain antibody fragment (scFv) Beovu, demonstrating significant improvement in central subfield thickness in Diabetic Macular Edema (DME).

Antibody

Antibody Regulation Development Trials

American Heart Association, Nov. 13-17

The Pharma Data

DECEMBER 1, 2020

The conference featured presentations focusing on the latest advances in cardiovascular medicine and surgery. The researchers found that increased adherence to healthy lifestyle behaviors was associated with lower all-cause mortality, regardless of medication burden. In a randomized controlled study, Nisa M. Press Release.

Medicine

Medicine Research Cardiology Hormones

Roche to present new data in multiple sclerosis and neuromyelitis optica spectrum disorder at MSVirtual2020

The Pharma Data

SEPTEMBER 2, 2020

New data further reinforce OCREVUS (ocrelizumab) as a highly effective treatment option offering a favourable and consistent benefit:risk profile, with high treatment persistence and adherence. Roche is also deeply committed to addressing barriers to clinical trial participation and advancing inclusive research.

Clinical Trials

Clinical Trials Clinical Trials Antibody Medicine

Comments on Notice of Proposed Rulemaking titled “Importation of Prescription Drugs, FDA-2019-N-5711, 84 Fed. Reg. 70796”

Pharmacy Checkers

MARCH 11, 2020

tolerates this magnitude of cost-related medication non-adherence, in which people die because of drug prices, should shock our national conscience. [2]. Recommendations to the FDA for adhering to Section 804 J(1). The FDA is aware that people with diabetes are going to Canada to import for personal use insulin products.

Pharmacy

Pharmacy Drugs FDA Approval Licensing

Clinical Research Informer

Controlling Diabetes: Advances & Adherence

How Heart Attack Survivors Can Improve Lifestyle Factors with a Text Messaging Program

Trending Sources

PI Focus: Velocity PI Leads Breakthrough Efforts to Combat Obesity, Diabetes

Up to 73% of Atopic Dermatitis Patients Taking Lilly’s Lebrikizumab Had Improved or Cleared Skin on Face or Hands in New Analysis

Bad behaviour: why understanding human behaviour can improve outcomes

Striving to Deliver Better Outcomes: Janssen to Showcase Commitment to.

Patient Centricity in Insulin Delivery: Improving the Injection Experience with Droplet Micron

Why aren’t digital pills taking off?

Fixed-dose combination of albuterol and budesonide (PT027) demonstrated significant benefits.

The Future Of Healthcare: Wearable Injectors Unveiled

Huma’s Kaushik Gune on SaMD and the Company’s Partnership with Bayer

The Future of Drug Delivery: Exploring Large Volume Wearable Injectors

Overcoming challenges in obesity-related clinical trials

Novartis’ KESTREL Study Reaffirms Positive Results of Beovu in DME

American Heart Association, Nov. 13-17

Roche to present new data in multiple sclerosis and neuromyelitis optica spectrum disorder at MSVirtual2020

Comments on Notice of Proposed Rulemaking titled “Importation of Prescription Drugs, FDA-2019-N-5711, 84 Fed. Reg. 70796”

Stay Connected